| Scmg Behavioral Health & Community Health Team | |
|
1 High St Wakefield RI 02879-3103 | |
| (401) 788-2310 | |
| (401) 788-8529 |
| Full Name | Scmg Behavioral Health & Community Health Team |
|---|---|
| Speciality | Clinic/Center |
| Location | 1 High St, Wakefield, Rhode Island |
| Authorized Official Name and Position | Thomas Breen (CFO) |
| Authorized Official Contact | 4017881605 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Scmg Behavioral Health & Community Health Team Po Box 229 Wakefield RI 02880-0229 Ph: (401) 788-8757 | Scmg Behavioral Health & Community Health Team 1 High St Wakefield RI 02879-3103 Ph: (401) 788-2310 |
| NPI Number | 1104871003 |
|---|---|
| Provider Enumeration Date | 05/23/2006 |
| Last Update Date | 12/18/2023 |
| Certification Date | 12/18/2023 |
| Medicare PECOS PAC ID | 4688661127 |
|---|---|
| Medicare Enrollment ID | O20060815000320 |
News Archive
Scientists have discovered a mechanism that causes an aggressive type of lung cancer to re-grow following chemotherapy, offering hope for new therapies.
Brains are able to adjust automatically to the demands of distinguishing between small differences in smell, new research at the University of Chicago shows.
A team of researchers at the California Institute of Technology (Caltech) has devised a new method for making complex molecules. The reaction they have come up with should enable chemists to synthesize new varieties of a whole subclass of organic compounds called nitrogen-containing heterocycles, thus opening up new avenues for the development of novel pharmaceuticals and natural products ranging from chemotherapeutic compounds to bioactive plant materials such as morphine.
Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of 8.75 million shares of its common stock at a price of $4.00 per share which will result in gross proceeds of $35 million.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104871003 | NPI | - | NPPES |
| Provider Name | Anthony Gallo |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1780622449 PECOS PAC ID: 7416934799 Enrollment ID: I20081113000364 |
News Archive
Scientists have discovered a mechanism that causes an aggressive type of lung cancer to re-grow following chemotherapy, offering hope for new therapies.
Brains are able to adjust automatically to the demands of distinguishing between small differences in smell, new research at the University of Chicago shows.
A team of researchers at the California Institute of Technology (Caltech) has devised a new method for making complex molecules. The reaction they have come up with should enable chemists to synthesize new varieties of a whole subclass of organic compounds called nitrogen-containing heterocycles, thus opening up new avenues for the development of novel pharmaceuticals and natural products ranging from chemotherapeutic compounds to bioactive plant materials such as morphine.
Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of 8.75 million shares of its common stock at a price of $4.00 per share which will result in gross proceeds of $35 million.
› Verified 2 days ago
| Provider Name | Cassandra Tibbits |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1013421858 PECOS PAC ID: 8123389608 Enrollment ID: I20180224000029 |
News Archive
Scientists have discovered a mechanism that causes an aggressive type of lung cancer to re-grow following chemotherapy, offering hope for new therapies.
Brains are able to adjust automatically to the demands of distinguishing between small differences in smell, new research at the University of Chicago shows.
A team of researchers at the California Institute of Technology (Caltech) has devised a new method for making complex molecules. The reaction they have come up with should enable chemists to synthesize new varieties of a whole subclass of organic compounds called nitrogen-containing heterocycles, thus opening up new avenues for the development of novel pharmaceuticals and natural products ranging from chemotherapeutic compounds to bioactive plant materials such as morphine.
Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of 8.75 million shares of its common stock at a price of $4.00 per share which will result in gross proceeds of $35 million.
› Verified 2 days ago
| Provider Name | Jessica Harrison |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1477914919 PECOS PAC ID: 7517296999 Enrollment ID: I20190910002822 |
News Archive
Scientists have discovered a mechanism that causes an aggressive type of lung cancer to re-grow following chemotherapy, offering hope for new therapies.
Brains are able to adjust automatically to the demands of distinguishing between small differences in smell, new research at the University of Chicago shows.
A team of researchers at the California Institute of Technology (Caltech) has devised a new method for making complex molecules. The reaction they have come up with should enable chemists to synthesize new varieties of a whole subclass of organic compounds called nitrogen-containing heterocycles, thus opening up new avenues for the development of novel pharmaceuticals and natural products ranging from chemotherapeutic compounds to bioactive plant materials such as morphine.
Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of 8.75 million shares of its common stock at a price of $4.00 per share which will result in gross proceeds of $35 million.
› Verified 2 days ago
| Provider Name | Holly B. Fuscaldo |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1639786619 PECOS PAC ID: 3678970472 Enrollment ID: I20210921003236 |
News Archive
Scientists have discovered a mechanism that causes an aggressive type of lung cancer to re-grow following chemotherapy, offering hope for new therapies.
Brains are able to adjust automatically to the demands of distinguishing between small differences in smell, new research at the University of Chicago shows.
A team of researchers at the California Institute of Technology (Caltech) has devised a new method for making complex molecules. The reaction they have come up with should enable chemists to synthesize new varieties of a whole subclass of organic compounds called nitrogen-containing heterocycles, thus opening up new avenues for the development of novel pharmaceuticals and natural products ranging from chemotherapeutic compounds to bioactive plant materials such as morphine.
Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of 8.75 million shares of its common stock at a price of $4.00 per share which will result in gross proceeds of $35 million.
› Verified 2 days ago
| Provider Name | Susan Pratt |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1952051385 PECOS PAC ID: 9830585207 Enrollment ID: I20220412000928 |
News Archive
Scientists have discovered a mechanism that causes an aggressive type of lung cancer to re-grow following chemotherapy, offering hope for new therapies.
Brains are able to adjust automatically to the demands of distinguishing between small differences in smell, new research at the University of Chicago shows.
A team of researchers at the California Institute of Technology (Caltech) has devised a new method for making complex molecules. The reaction they have come up with should enable chemists to synthesize new varieties of a whole subclass of organic compounds called nitrogen-containing heterocycles, thus opening up new avenues for the development of novel pharmaceuticals and natural products ranging from chemotherapeutic compounds to bioactive plant materials such as morphine.
Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of 8.75 million shares of its common stock at a price of $4.00 per share which will result in gross proceeds of $35 million.
› Verified 2 days ago
| Provider Name | Olivia Dorsey |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1801588827 PECOS PAC ID: 7012374820 Enrollment ID: I20230609002835 |
News Archive
Scientists have discovered a mechanism that causes an aggressive type of lung cancer to re-grow following chemotherapy, offering hope for new therapies.
Brains are able to adjust automatically to the demands of distinguishing between small differences in smell, new research at the University of Chicago shows.
A team of researchers at the California Institute of Technology (Caltech) has devised a new method for making complex molecules. The reaction they have come up with should enable chemists to synthesize new varieties of a whole subclass of organic compounds called nitrogen-containing heterocycles, thus opening up new avenues for the development of novel pharmaceuticals and natural products ranging from chemotherapeutic compounds to bioactive plant materials such as morphine.
Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of 8.75 million shares of its common stock at a price of $4.00 per share which will result in gross proceeds of $35 million.
› Verified 2 days ago
| Provider Name | Elizabeth Fortin |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1396428728 PECOS PAC ID: 7810341666 Enrollment ID: I20230927001562 |
News Archive
Scientists have discovered a mechanism that causes an aggressive type of lung cancer to re-grow following chemotherapy, offering hope for new therapies.
Brains are able to adjust automatically to the demands of distinguishing between small differences in smell, new research at the University of Chicago shows.
A team of researchers at the California Institute of Technology (Caltech) has devised a new method for making complex molecules. The reaction they have come up with should enable chemists to synthesize new varieties of a whole subclass of organic compounds called nitrogen-containing heterocycles, thus opening up new avenues for the development of novel pharmaceuticals and natural products ranging from chemotherapeutic compounds to bioactive plant materials such as morphine.
Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of 8.75 million shares of its common stock at a price of $4.00 per share which will result in gross proceeds of $35 million.
› Verified 2 days ago
| Provider Name | Ashley A. Foster |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1356969588 PECOS PAC ID: 0345693875 Enrollment ID: I20240131002410 |
News Archive
Scientists have discovered a mechanism that causes an aggressive type of lung cancer to re-grow following chemotherapy, offering hope for new therapies.
Brains are able to adjust automatically to the demands of distinguishing between small differences in smell, new research at the University of Chicago shows.
A team of researchers at the California Institute of Technology (Caltech) has devised a new method for making complex molecules. The reaction they have come up with should enable chemists to synthesize new varieties of a whole subclass of organic compounds called nitrogen-containing heterocycles, thus opening up new avenues for the development of novel pharmaceuticals and natural products ranging from chemotherapeutic compounds to bioactive plant materials such as morphine.
Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of 8.75 million shares of its common stock at a price of $4.00 per share which will result in gross proceeds of $35 million.
› Verified 2 days ago
| Provider Name | Michelle Kurzbach |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1710669577 PECOS PAC ID: 0345685020 Enrollment ID: I20240304003844 |
News Archive
Scientists have discovered a mechanism that causes an aggressive type of lung cancer to re-grow following chemotherapy, offering hope for new therapies.
Brains are able to adjust automatically to the demands of distinguishing between small differences in smell, new research at the University of Chicago shows.
A team of researchers at the California Institute of Technology (Caltech) has devised a new method for making complex molecules. The reaction they have come up with should enable chemists to synthesize new varieties of a whole subclass of organic compounds called nitrogen-containing heterocycles, thus opening up new avenues for the development of novel pharmaceuticals and natural products ranging from chemotherapeutic compounds to bioactive plant materials such as morphine.
Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of 8.75 million shares of its common stock at a price of $4.00 per share which will result in gross proceeds of $35 million.
› Verified 2 days ago
News Archive
Scientists have discovered a mechanism that causes an aggressive type of lung cancer to re-grow following chemotherapy, offering hope for new therapies.
Brains are able to adjust automatically to the demands of distinguishing between small differences in smell, new research at the University of Chicago shows.
A team of researchers at the California Institute of Technology (Caltech) has devised a new method for making complex molecules. The reaction they have come up with should enable chemists to synthesize new varieties of a whole subclass of organic compounds called nitrogen-containing heterocycles, thus opening up new avenues for the development of novel pharmaceuticals and natural products ranging from chemotherapeutic compounds to bioactive plant materials such as morphine.
Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of 8.75 million shares of its common stock at a price of $4.00 per share which will result in gross proceeds of $35 million.
› Verified 2 days ago
Kathleen Levy Lmft Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 24 Salt Pond Rd Ste B4, Wakefield, RI 02879 Phone: 401-788-9500 Fax: 401-788-9500 | |
Of The Heart, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 66 Main St, Wakefield, RI 02879 Phone: 401-339-0521 | |
Cmb Wellness Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 231 Old Tower Hill Rd Ste 208, Wakefield, RI 02879 Phone: 401-284-7414 Fax: 949-655-2738 | |
Bertram Gibbes, Ph.d., Inc. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 481a Kingstown Rd, Suite D, Wakefield, RI 02879 Phone: 401-782-1667 Fax: 104-782-1669 | |
Burrows Mental Health Counseling Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 30 Holley St, Wakefield, RI 02879 Phone: 401-284-0446 Fax: 401-284-3236 | |
Delta Consultants Of South County Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 24 Salt Pond Road, Suite D4 South Kingstown Office Park, Wakefield, RI 02879 Phone: 401-789-3694 Fax: 401-789-3748 |